Queen Alexandra Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Chronic kidney disease1 trial
• High blood pressure1 trial
• Prostate cancer1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Boehringer Ingelheim2 trials
• Medical Research Council1 trial

Running trials

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Boehringer Ingelheim· Source

• Active, not recruiting

  Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

  NCT00268476· Phase 2/3· Medical Research Council· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting
• Type 2 diabetes1 recruiting